Live from the NIH registry
Studies recruiting near Myrtle Beach right now
Top 25 of 86 recruiting studies, sorted by proximity — each links to its official registry page
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Transitional Cell Cancer of Renal Pelvis and Ureter
Phase 3
Interventional 100 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Steba Biotech S.A.
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
Cataract
Phase 3
Interventional 528 participants sought
Conway Ophthalmology — Conway, South Carolina (12.8 mi)
· Sponsor: Melt Pharmaceuticals
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Prostate Cancer (Adenocarcinoma), Prostate CA
Phase 2
Interventional 100 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Cellvax Therapeutics Inc
The CONFORM Pivotal Trial
Atrial Fibrillation, Stroke
N/A
Interventional 1,600 participants sought
HCA Grand Strand — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Conformal Medical, Inc
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Prostatic Neoplasms, Castration-Resistant
Phase 3
Interventional 800 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12111 — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Phase 3
Interventional 250 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Ferring Pharmaceuticals
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
Prostate Adenocarcinoma
Phase 1
Interventional 56 participants sought
Atlantic Urology Specialists — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Alessa Therapeutics Inc.
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Phase 3
Interventional 450 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Novartis Pharmaceuticals
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Non-muscle Invasive Bladder Cancer
Phase 1
Interventional 294 participants sought
Grand Strand Medical Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Pfizer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Carolina Regional Cancer Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: NRG Oncology
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Bladder (Urothelial, Transitional Cell) Cancer, Non-Muscle Invasive Bladder Carcinoma
Phase 3
Interventional 284 participants sought
START - Carolinas — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Protara Therapeutics
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Prostate Cancer, Prostatic Neoplasms
Phase 3
Interventional 383 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Clarity Pharmaceuticals Ltd
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Low-grade NMIBC, FGFR Gene Amplification
Phase 2
Interventional 90 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Tyra Biosciences, Inc
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Phase 1, Phase 2
Interventional 235 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Phase 2
Interventional 900 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Metastatic Castration-resistant Prostate Cancer
Phase 3
Interventional 670 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: AstraZeneca
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
Hidradenitis Suppurativa
Phase 3
Interventional 550 participants sought
Investigative Site US041 — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Incyte Corporation
A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
Prostate Cancer
Phase 1, Phase 2
Interventional 300 participants sought
Research Site — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: AstraZeneca
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer (Adenocarcinoma)
Phase 2
Interventional 45 participants sought
START Carolinas — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Candel Therapeutics, Inc.
The ArtixASCEND Study
Acute Lower Limb Arterial Occlusion
N/A
Interventional 250 participants sought
Grand Strand Medical Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Inari Medical
STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
Tobacco Use, Substance Use Disorders
N/A
Interventional 240 participants sought
Shoreline Behavioral Health Services — Conway, South Carolina (12.8 mi)
· Sponsor: Medical University of South Carolina
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
Solid Tumor
Phase 1
Interventional 140 participants sought
Site-112 — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Biohaven Therapeutics Ltd.
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
Metastatic Castration-Resistant Prostate Cancer
Phase 2
Interventional 100 participants sought
Carolina Urologic Research Center — Myrtle Beach, South Carolina (1.4 mi)
· Sponsor: Hoffmann-La Roche